Medicenna Therapeutics Corp. (MDNAF)
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
Address
2 BLOOR ST W., 7TH FLOOR
TORONTO, A6 M4W 3E2
Founded
2015
Number of Employees
16
Website
http://www.medicenna.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)